Research |
![]() ![]() ![]() ![]() ![]() |
Serial Number | 87083372 |
Registration Number | 6102316 |
Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
Attorney Name | Scott W. Johnston |
Attorney Docket Number | 13288.42US02 |
Law Office Assigned | M70 |
Employee Name | FRUM MILONE, MARCIE R |
1999-08-00 | Date of First Use |
2016-06-24 | Application Filed |
2017-06-13 | Published for Opposition |
2019-12-11 | Location: TMO LAW OFFICE 116 - EXAMINING ATTORNEY ASSIGNED |
2019-12-11 | Status: Live/Pending |
2019-12-11 | Transaction Date |
2020-07-14 | Trademark Registered |
Owner: | ![]() |
Address | 9924 West 74th Street Eden Prairie MN 55344 |
Legal Entity Type | Corporation |
Legal Entity State | MN |
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
International Codes: | 1 |
U.S. Codes: | 001,005,006,010,026,046 |
International Codes: | 2 |
U.S. Codes: | 006,011,016 |
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
International Codes: | 9 |
U.S. Codes: | 021,023,026,036,038 |
International Codes: | 10 |
U.S. Codes: | 026,039,044 |
International Codes: | 40 |
U.S. Codes: | 100,103,106 |
International Codes: | 42 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
GS0011 | Reagents for scientific or medical research use; Photoreactive chemical coating compositions for industrial, including medical, use; Chemicals for use in the manufacture of medical device coatings; Chemical preparations for scientific purposes used for blocking and antibody dilution in blotting applications; chemical preparations for scientific purposes for use with analytical procedures in research and diagnostic applications; Liquid preparation for use in stabilizing reagents employed in immunoassays; Chemical solutions for stabilizing biological molecules for scientific or medical research use and for use in the manufacture of medical devices; Chemicals namely, a chemical solution for use in preserving analytical reagents for scientific and research use; photoreactive chemical coating compositions for general industrial use, and for use in the manufacture of medical devices and diagnostic test devices; Diagnostic assay kits composed primarily of DNA assay substrates and reagents; diagnostic assay components, namely, DNA assay substrates and reagents; Chemicals for use in the manufacture of coatings for medical devices; chemicals for use in the manufacture of drug eluting coatings; chemicals for use in the manufacture of drug delivery coatings; Biopolymer based coatings for use in the manufacture of implantable medical devices, namely, coatings containing extracellular matrix proteins designed to improve and accelerate tissue healing of implantable medical devices |
GS0011 | Reagents for scientific or medical research use; Photoreactive chemical coating compositions for industrial, including medical, use; Chemicals for use in the manufacture of medical device coatings; Chemical preparations for scientific purposes used for blocking and antibody dilution in blotting applications; chemical preparations for scientific purposes for use with analytical procedures in research and diagnostic applications; Liquid preparation for use in stabilizing reagents employed in immunoassays; Chemical solutions for stabilizing biological molecules for scientific or medical research use and for use in the manufacture of medical devices; Chemicals namely, a chemical solution for use in preserving analytical reagents for scientific and research use; photoreactive chemical coating compositions for general industrial use, and for use in the manufacture of medical devices and diagnostic test devices; Diagnostic assay kits composed primarily of DNA assay substrates and reagents; diagnostic assay components, namely, DNA assay substrates and reagents; Chemicals for use in the manufacture of coatings for medical devices; chemicals for use in the manufacture of drug eluting coatings; chemicals for use in the manufacture of drug delivery coatings; Biopolymer based coatings for use in the manufacture of implantable medical devices, namely, coatings containing extracellular matrix proteins designed to improve and accelerate tissue healing of implantable medical devices |
Description | Date | Event Coding |
---|---|---|
NEW APPLICATION ENTERED IN TRAM | 2016-06-28 | 1 NWAP I:Incoming Correspondence |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2016-06-29 | 2 NWOS I:Incoming Correspondence |
ASSIGNED TO EXAMINER | 2016-09-30 | 3 DOCK D:Assigned to Examiner |
EXAMINERS AMENDMENT -WRITTEN | 2016-09-30 | 4 CNEA R:Renewal |
EXAMINERS AMENDMENT E-MAILED | 2016-09-30 | 5 GNEA F:First Action |
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2016-09-30 | 6 GNEN O:Outgoing Correspondence |
EXAMINER'S AMENDMENT ENTERED | 2016-09-30 | 7 XAEC I:Incoming Correspondence |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2016-09-30 | 8 CNSA P: |
ASSIGNED TO LIE | 2016-10-17 | 9 ALIE A:Allowance for Publication |
LAW OFFICE PUBLICATION REVIEW COMPLETED | 2016-10-17 | 10 PREV O:Outgoing Correspondence |
WITHDRAWN FROM PUB - OG REVIEW QUERY | 2016-11-01 | 11 PBCR Z:Deletion |
PREVIOUS ALLOWANCE COUNT WITHDRAWN | 2016-11-09 | 12 ZZZX Z:Deletion |
NON-FINAL ACTION WRITTEN | 2016-11-27 | 13 CNRT R:Renewal |
NON-FINAL ACTION E-MAILED | 2016-11-27 | 14 GNRT O:Outgoing Correspondence |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2016-11-27 | 15 GNRN O:Outgoing Correspondence |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2017-04-04 | 16 TROA I:Incoming Correspondence |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2017-04-04 | 17 TROA I:Incoming Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2017-04-04 | 18 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2017-04-05 | 19 TEME I:Incoming Correspondence |
EXAMINERS AMENDMENT -WRITTEN | 2017-04-28 | 20 CNEA R:Renewal |
EXAMINERS AMENDMENT E-MAILED | 2017-04-28 | 21 GNEA O:Outgoing Correspondence |
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2017-04-28 | 22 GNEN O:Outgoing Correspondence |
EXAMINER'S AMENDMENT ENTERED | 2017-04-28 | 23 XAEC I:Incoming Correspondence |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2017-04-28 | 24 CNSA P: |
LAW OFFICE PUBLICATION REVIEW COMPLETED | 2017-05-06 | 25 PREV O:Outgoing Correspondence |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2017-05-24 | 26 NONP E:E-Mail |
PUBLISHED FOR OPPOSITION | 2017-06-13 | 27 PUBO A:Allowance for Publication |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2017-06-13 | 28 NPUB E:E-Mail |
NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2017-08-08 | 29 NOAM E:E-Mail |
TEAS EXTENSION RECEIVED | 2018-01-30 | 30 EEXT I:Incoming Correspondence |
EXTENSION 1 FILED | 2018-01-30 | 31 EXT1 S: |
EXTENSION 1 GRANTED | 2018-01-30 | 32 EX1G S: |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2018-02-01 | 33 EXRA E:E-Mail |
TEAS EXTENSION RECEIVED | 2018-08-07 | 34 EEXT I:Incoming Correspondence |
EXTENSION 2 FILED | 2018-08-07 | 35 EXT2 S: |
EXTENSION 2 GRANTED | 2018-08-07 | 36 EX2G S: |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2018-08-09 | 37 EXRA E:E-Mail |
TEAS EXTENSION RECEIVED | 2019-02-08 | 38 EEXT I:Incoming Correspondence |
EXTENSION 3 FILED | 2019-02-08 | 39 EXT3 S: |
EXTENSION 3 GRANTED | 2019-02-08 | 40 EX3G S: |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2019-02-12 | 41 EXRA E:E-Mail |
TEAS STATEMENT OF USE RECEIVED | 2019-08-08 | 42 EISU I:Incoming Correspondence |
CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2019-09-07 | 43 AITU A:Allowance for Publication |
USE AMENDMENT FILED | 2019-08-08 | 44 IUAF S: |
STATEMENT OF USE PROCESSING COMPLETE | 2019-09-07 | 45 SUPC I:Incoming Correspondence |
SU - NON-FINAL ACTION - WRITTEN | 2019-09-13 | 46 CNRT W: |
NON-FINAL ACTION E-MAILED | 2019-09-13 | 47 GNRT O:Outgoing Correspondence |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2019-09-13 | 48 GNRN O:Outgoing Correspondence |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2019-10-28 | 49 TROA I:Incoming Correspondence |
ASSIGNED TO LIE | 2019-11-04 | 50 ALIE A:Allowance for Publication |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2019-11-04 | 51 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2019-11-04 | 52 TEME I:Incoming Correspondence |
SU - FINAL REFUSAL - WRITTEN | 2019-12-10 | 53 CNFR W: |
SU - FINAL REFUSAL - WRITTEN | 2019-12-10 | 54 CNFR W: |
SU - FINAL REFUSAL - WRITTEN | 2019-12-11 | 55 CNFR W: |
SU - FINAL REFUSAL - WRITTEN | 2019-12-11 | 56 CNFR W: |
FINAL REFUSAL E-MAILED | 2019-12-11 | 57 GNFR O:Outgoing Correspondence |
NOTIFICATION OF FINAL REFUSAL EMAILED | 2019-12-11 | 58 GNFN O:Outgoing Correspondence |
TEAS REQUEST FOR RECONSIDERATION RECEIVED | 2020-06-02 | 59 ERFR I:Incoming Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2020-06-04 | 60 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2020-06-04 | 61 TEME I:Incoming Correspondence |
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2020-06-06 | 62 CNPR P: |
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 2020-06-09 | 63 SUNA E:E-Mail |
REGISTERED-PRINCIPAL REGISTER | 2020-07-14 | 64 R.PR A:Allowance for Publication |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.